← brief for 2026-10-20 · Transplant & xeno

Prescribing patterns and impact of glucagon-like peptide-1 receptor agonists in a kidney transplant evaluation cohort in British Columbia, Canada A single-center experience.

Article C Peer reviewed Observational

Key takeaways

This study looked at 2,789 people being evaluated for a kidney transplant. It is a retrospective review, so it shows a link, not proof of cause. The doctors tracked how many people were on a weight-loss drug called a GLP-1RA and what happened to their weight.

Who did this work

Chae HH · Luo C · Harriman D · Nguan C

Source

Article · PubMed, the drug frontier · 2026 Oct
https://pubmed.ncbi.nlm.nih.gov/42900879/